demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 hospitalized
acalabrutinib CALAVI CALAVI US

1 studies excluded by filtering options 1

6323 Roschewski, 2020 2990excludednot a RCTrisk of bias not avaialble